IZEA director granted 4,054 shares as fees

Caron John H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Caron John H reported acquisition or exercise transactions in this Form 4 filing.

IZEA Worldwide, Inc. director John H. Caron received a grant of 4,054 shares of restricted common stock as Q2 2026 director fees. The award was valued at $15,000 based on a $3.70 closing price on June 30, 2026 and vested immediately. Following the grant, he holds 110,469 shares directly and 5,000 shares indirectly through the John H. Caron 1999 Family Trust, over which he has voting and investment power.

Insider Trade Summary 10b5-1

Grant/Award: 4,054 shares

Grant/Award 2 txns

Insider Caron John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,054	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 110,469 shares (Direct); Common Stock — 5,000 shares (Indirect, By John H. Caron 1999 Family Trust)

Footnotes (2)

1. F1. Restricted Stock received for Q2 2026 director fees valued at $15,000 based on the closing market price of $3.70 on the grant date of June 30, 2026. Award vests immediately at the grant date.
2. F2. John H. Caron, as trustee, has voting power and investment power over the securities held by the John H. Caron 1999 Family Trust.

Key Figures

Restricted shares granted: 4,054 shares Grant value: $15,000 Reference share price: $3.70 per share +2 more

5 metrics

Restricted shares granted 4,054 shares Q2 2026 director fees award

Grant value $15,000 Restricted stock compensation for Q2 2026 director fees

Reference share price $3.70 per share Closing market price on June 30, 2026 used for valuation

Direct holdings after grant 110,469 shares Common stock directly owned following the award

Indirect trust holdings 5,000 shares Held by John H. Caron 1999 Family Trust

Key Terms

Restricted Stock, director fees, voting power, investment power, +1 more

5 terms

Restricted Stock financial

"Restricted Stock received for Q2 2026 director fees valued at $15,000"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

director fees financial

"Restricted Stock received for Q2 2026 director fees valued at $15,000"

voting power financial

"has voting power and investment power over the securities held"

Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.

investment power financial

"has voting power and investment power over the securities held"

Family Trust financial

"securities held by the John H. Caron 1999 Family Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IZEA (IZEA) director John H. Caron report in this Form 4?

Director John H. Caron reported receiving 4,054 shares of restricted common stock as Q2 2026 director fees. The award is compensation, not an open-market purchase or sale, and reflects routine equity-based payment for board service.

How much is John H. Caron’s IZEA stock grant worth from this filing?

The restricted stock grant was valued at $15,000, based on IZEA’s $3.70 closing market price on June 30, 2026. This value represents the equity portion of his Q2 2026 director fees, which vested in full at the grant date.

How many IZEA shares did John H. Caron receive in the latest award?

He received 4,054 shares of IZEA restricted common stock. These shares were granted as compensation for Q2 2026 director fees and carried a stated value of $15,000 based on the company’s market price on the grant date.

When did John H. Caron’s IZEA restricted stock award vest?

The restricted stock award vested immediately on the June 30, 2026 grant date. Immediate vesting means the shares were fully earned at once, without a multi-year vesting schedule often seen in longer-term equity incentive awards.

How many IZEA shares does John H. Caron hold after this Form 4?

After the grant, he directly holds 110,469 IZEA common shares. In addition, a separate Form 4 entry shows 5,000 shares held indirectly by the John H. Caron 1999 Family Trust, over which he has voting and investment power as trustee.

Is the IZEA Form 4 transaction a market buy or sell by John H. Caron?

No, the Form 4 reflects a grant of restricted stock as director compensation, not an open-market trade. The shares were awarded at a stated price of $3.70 and valued at $15,000, vesting immediately at grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caron John H

(Last) (First) (Middle)

1317 EDGEWATER DR #1880

(Street)

ORLANDO FLORIDA 32804

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IZEA Worldwide, Inc. [ IZEA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		4,054(1)	A	$0	110,469	D
Common Stock								5,000	I	By John H. Caron 1999 Family Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock received for Q2 2026 director fees valued at $15,000 based on the closing market price of $3.70 on the grant date of June 30, 2026. Award vests immediately at the grant date.

2. John H. Caron, as trustee, has voting power and investment power over the securities held by the John H. Caron 1999 Family Trust.

Remarks:

	By: /s/ Peter J. Biere as attorney-in-fact for John H. Caron	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)